The Madeira Chemistry Research Centre (CQM) is a founding member of PT-OPENSCREEN, a network recently created in Portugal, whose main objective is to create an infrastructure of high-throughput screening platforms using robotic systems, which allow thousands of daily tests to be carried out to identify new molecules with biological/therapeutic potential.

The participation of CQM in PT-OPENSCREEN, involves the availability of chemical compounds that are currently being studied in its laboratories and that have already shown to be promising for the treatment of cancer and infectious diseases, such as AIDS. In the future high capacity screening center, these compounds will be able to be quickly screened to see if they will eventually be effective in other pathologies as well.

Watch interview here (RTP-M): https://www.rtp.pt/play/p85/e476856/telejornal-madeira (17:52)